-
Mashup Score: 1ACC CardiaCast: Exploring HF&T Highlights from ACC.24: RELIEVE-HF, REDUCE AMI, and DANGER-Shock Trials - American College of Cardiology - 6 hour(s) ago
Dive into the Heart of ACC.24’s Heart Failure and Transplant Highlights! In this podcast, Drs. Maya Guglin, Shelley Hall, Onyedika Ilonze, and Kazuhiko Kido dissect the most captivating advancements and groundbreaking rev elations from the ACC.24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI, and DanGer Shock. Join us as we navigate through the latest research, innovative therapies, and paradigm-shifting insights that promise to reshape the landscape of cardiovascular
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 400Transcatheter or Surgical Treatment of Aortic-Valve Stenosis | NEJM - 15 hour(s) ago
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 400
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 401
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 401
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lack…
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Spirituality Intervention Tied to Lower Blood Pressure - 7 day(s) ago
An intervention meant to foster a positive outlook significantly improved endothelial function and lowered blood pressure, show preliminary results of the FEEL study.
Source: www.medscape.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 10Beyond the Data: REDUCE-AMI - 7 day(s) ago
Troels Yndigegn and Sripal Bangalore discuss the inutility of beta-blockers in modern-day post-MI care in patients with preserved EF.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Beyond the Data: REDUCE-AMI - 8 day(s) ago
Troels Yndigegn and Sripal Bangalore discuss the inutility of beta-blockers in modern-day post-MI care in patients with preserved EF.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10
For patients who can’t—or won’t—use CPAP, the new findings point toward a tantalizing alternative.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 22
In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed, as well as lipid management for women, Hispanic, Latinx, and obese patients in the CLEAR Outcomes Trial. Educational grant support is provided by Esperion.  Cho L, Plutzky J, B rennan D, et al. Characteristics
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
On ACC CardiaCast podcast, Drs. @MGuglin, @shelleyhallmd, @Aheartdoc and @KazuhikoKido dissect groundbreaking science from the #ACC24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI & DanGer Shock. 🎧 https://t.co/qZeB6674Gg https://t.co/jXQ7S5ztQM